Praxair Surface Technologies (PX), GE Aviation Create New PG Technologies Joint Venture
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Praxair Surface Technologies, Inc., a wholly owned subsidiary of Praxair, Inc. (NYSE: PX), and GE Aviation announced the formal creation of PG Technologies, LLC, a joint venture. Praxair Surface Technologies and its subsidiary will hold the majority interest in the venture with GE Aviation and its subsidiary holding the remainder.
PG Technologies will focus on development, support and application of specialized coatings tailored for GE Aviation’s and CFM International’s current and future engine models, including the GE9X and LEAP engines. CFM International is a 50/50 joint venture company between GE and Safran Aircraft Engines of France.
“The formation of PG Technologies builds upon decades of collaboration between Praxair Surface Technologies and GE Aviation. This joint venture will take the leadership role in the next generation of coating technology applications and will invest in new coating production capacity to meet the needs of the burgeoning aviation sector,” said PG Technologies Board Member and Praxair Surface Technologies President Pierre Lüthi.
“PG Technologies will play an important role in GE Aviation’s engine manufacturing system,” said Colleen Athans, vice president and general manager of GE Aviation’s Supply Chain. “With engine production volume levels growing, GE’s need for specialized coatings will also increase, and this joint venture will ensure we meet our commitments on the performance and durability of our engines.”
Coating operations for PG Technologies will be based in Ellisville, Mississippi, Indianapolis, Indiana, and the Republic of Singapore. PG Technologies services will also be supported by the global facility network of Praxair Surface Technologies.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Finjan Holdings (FNJN) Receives European Patent Related to Adaptive Rule-Based Content Scanners
- Histogenics (HSGX) Reaches 75% Enrollment Milestone in NeoCart Phase 3
- Immunomedics (IMMU) Taps Greenhill & Co. as Strategic Advisor; Will Assist in IMMU-132 Out-Licensing
Create E-mail Alert Related CategoriesCorporate News, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!